ACPE Activity Number: 0204-0000-23-060-H01-P
Release Date: 03/11/2023
Expiration Date: 03/11/2025
Activity Type: Knowledge-based
CE Credits: 0.5 contact hour, no partial credit
Activity Fee: Member – Free / Non-Member – Not Available
Pharmacists providing care for patients in the emergent setting are unaware of the practical and evidence-based considerations for the use of ketamine for acute analgesia, procedural sedation, and acute agitation. In this episode, pharmacists will learn about the place in therapy of ketamine in the emergent setting, identify ideal candidates for ketamine use in the emergency department setting and be able to recommend appropriate administration, dosing, and monitoring recommendations when using ketamine in the emergency setting.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
After participating in this CPE activity, participants should be able to:
- Describe indications, dosing, routes of administration, and monitoring considerations for ketamine in the emergency department setting.
- Discuss the advantages and disadvantages of ketamine use in the emergency department setting.
- Identify patient populations who are good candidates for ketamine use in the emergency setting.
Introduction and Announcements
Lance Ray, PharmD
Emergency Medicine Clinical Specialist and PGY2 EM Residency Program Director
Denver Health and Hospital Authority
Andrew P. Smith
Emergency Medicine Pharmacist Specialist and PGY2 EM Residency Program Director
Scripps Mercy Hospital
San Diego, CA
Emergency Medicine Clinical Pharmacist
San Francisco General Hospital
San Francisco, CA
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.